SOPHARMA (SPH): current report 124 inf. za kfn11.2012 ENG - raport 124

UNI - EN REPORT No 124/2012
Podstawa prawna:

Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osŃ�b maj"��cych dostĐşp do informacji poufnych

The Board of Directors of Sopharma AD (the "Company") notifies that for November 2012 sales revenues remained at the same level compared to the same period of 2011, including 1% increase of export sales and no changes in domestic sales.

During the first eleven months of this year Sopharma AD recorded an increase of sales revenues of 2%, including 9% decrease of domestic sales and 6% increase of export sales compared to the same period of 2011.

Annexes:

File;

Załączniki